{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:29:02Z","timestamp":1777408142480,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":4705,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1186\/2110-5820-3-17","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T12:15:00Z","timestamp":1372335300000},"page":"17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Control of hypertension in the critically ill: a pathophysiological approach"],"prefix":"10.1016","volume":"3","author":[{"given":"Diamantino Ribeiro","family":"Salgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1186\/2110-5820-3-17_bb0010","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1186\/2110-5820-3-17_bb0015","first-page":"e25","article-title":"Heart disease and stroke statistics\u20132008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"10.1186\/2110-5820-3-17_bb0020","doi-asserted-by":"crossref","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","article-title":"The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors","volume":"6","author":"Danaei","year":"2009","journal-title":"PLoS Med"},{"key":"10.1186\/2110-5820-3-17_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1751-7176.2010.00394.x","article-title":"Blood pressure control in acute cerebrovascular disease","volume":"13","author":"Owens","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1186\/2110-5820-3-17_bb0030","first-page":"S2","article-title":"Hypertensive urgencies and emergencies","volume":"14","author":"Shafi","year":"2004","journal-title":"Ethn Dis"},{"key":"10.1186\/2110-5820-3-17_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1751-7133.2008.00047.x","article-title":"Initial emergency department systolic blood pressure predicts left ventricular systolic function in acute decompensated heart failure","volume":"15","author":"Styron","year":"2009","journal-title":"Congest Heart Fail"},{"key":"10.1186\/2110-5820-3-17_bb0040","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.109.896597","article-title":"Acute kidney injury and cardiovascular outcomes in acute severe hypertension","volume":"121","author":"Szczech","year":"2010","journal-title":"Circulation"},{"key":"10.1186\/2110-5820-3-17_bb0045","doi-asserted-by":"crossref","first-page":"R271","DOI":"10.1186\/cc10551","article-title":"Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT)","volume":"15","author":"Vuylsteke","year":"2011","journal-title":"Crit Care"},{"key":"10.1186\/2110-5820-3-17_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.annemergmed.2008.04.025","article-title":"Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension","volume":"53","author":"Pollack","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1186\/2110-5820-3-17_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.07.020","article-title":"Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry","volume":"158","author":"Katz","year":"2009","journal-title":"Am Heart J"},{"key":"10.1186\/2110-5820-3-17_bb0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ahj.2010.06.032","article-title":"Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study","volume":"160","author":"Gore","year":"2010","journal-title":"Am Heart J"},{"key":"10.1186\/2110-5820-3-17_bb0065","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/CCM.0b013e3182227238","article-title":"Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registry","volume":"39","author":"Mayer","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1186\/2110-5820-3-17_bb0070","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ajem.2010.03.022","article-title":"Hypertensive heart failure: patient characteristics, treatment, and outcomes","volume":"29","author":"Peacock","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1186\/2110-5820-3-17_bb0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/cc2351","article-title":"Clinical review: the management of hypertensive crises","volume":"7","author":"Varon","year":"2003","journal-title":"Crit Care"},{"key":"10.1186\/2110-5820-3-17_bb0080","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.06-2490","article-title":"Hypertensive crises: challenges and management","volume":"131","author":"Marik","year":"2007","journal-title":"Chest"},{"key":"10.1186\/2110-5820-3-17_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3810\/pgm.2009.01.1950","article-title":"The diagnosis and treatment of hypertensive crises","volume":"121","author":"Varon","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1186\/2110-5820-3-17_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/08037051.2010.488052","article-title":"Hypertension crisis","volume":"19","author":"Papadopoulos","year":"2010","journal-title":"Blood Press"},{"key":"10.1186\/2110-5820-3-17_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccl.2012.07.011","article-title":"Hypertension crisis in the emergency department","volume":"30","author":"Johnson","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1186\/2110-5820-3-17_bb0100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1186\/2110-5820-3-17_bb0105","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/cc3753","article-title":"The microcirculation is the motor of sepsis","volume":"9","author":"Ince","year":"2005","journal-title":"Crit Care"},{"key":"10.1186\/2110-5820-3-17_bb0110","first-page":"S6","article-title":"Overview of physiology, vascular biology, and mechanisms of hypertension","volume":"13","author":"Cohen","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1186\/2110-5820-3-17_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00395-009-0775-y","article-title":"Vascular control in humans: focus on the coronary microcirculation","volume":"104","author":"Liu","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1186\/2110-5820-3-17_bb0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.semnephrol.2010.09.007","article-title":"Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker","volume":"30","author":"Robinson","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1186\/2110-5820-3-17_bb0125","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1378\/chest.07-0073","article-title":"Hemodynamic evaluation and monitoring in the ICU","volume":"132","author":"Pinsky","year":"2007","journal-title":"Chest"},{"key":"10.1186\/2110-5820-3-17_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/adc.88.1.46","article-title":"Monitoring cardiac function in intensive care","volume":"88","author":"Tibby","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1186\/2110-5820-3-17_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bmj.1.5852.507","article-title":"Autoregulation of brain circulation in severe arterial hypertension","volume":"1","author":"Strandgaard","year":"1973","journal-title":"Br Med J"},{"key":"10.1186\/2110-5820-3-17_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.hco.0000231396.56738.d8","article-title":"Hypertension in the intensive care unit","volume":"21","author":"Slama","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1186\/2110-5820-3-17_bb0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jclinane.2008.09.003","article-title":"Perioperative hypertension: a review of current and emerging therapeutic agents","volume":"21","author":"Marik","year":"2009","journal-title":"J Clin Anesth"},{"key":"10.1186\/2110-5820-3-17_bb0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1152\/physrev.00045.2006","article-title":"Regulation of coronary blood flow during exercise","volume":"88","author":"Duncker","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1186\/2110-5820-3-17_bb0155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0003-4975(95)90009-8","article-title":"Effect of sodium nitroprusside on paraplegia during cross-clamping of the thoracic aorta","volume":"56","author":"Cernaianu","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1186\/2110-5820-3-17_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0736-4679(97)00287-4","article-title":"Parenteral hydralazine revisited","volume":"16","author":"Powers","year":"1998","journal-title":"J Emerg Med"},{"key":"10.1186\/2110-5820-3-17_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0014-2999(96)00972-7","article-title":"Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery","volume":"321","author":"Wei","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1186\/2110-5820-3-17_bb0170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/clpt.1980.229","article-title":"Hydralazine kinetics in hypertensive patients after intravenous administration","volume":"28","author":"Ludden","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1186\/2110-5820-3-17_bb0175","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1186\/2110-5820-3-17_bb0180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2125.2011.04002.x","article-title":"How to manage hypertension in pregnancy effectively","volume":"72","author":"Magee","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1186\/2110-5820-3-17_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-9343(93)90256-O","article-title":"Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function","volume":"95","author":"Shusterman","year":"1993","journal-title":"Am J Med"},{"key":"10.1186\/2110-5820-3-17_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0895-7061(99)00059-X","article-title":"Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises","volume":"12","author":"Oparil","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1186\/2110-5820-3-17_bb0195","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMra010253","article-title":"Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension","volume":"345","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1186\/2110-5820-3-17_bb0200","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.1995.00430200107014","article-title":"Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises","volume":"155","author":"Hirschl","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1186\/2110-5820-3-17_bb0205","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2146\/ajhp080348.p2","article-title":"Intravenous therapy for hypertensive emergencies, part 2","volume":"66","author":"Rhoney","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1186\/2110-5820-3-17_bb0210","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3171\/JNS.2008.109.12.1065","article-title":"Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation","volume":"109","author":"Narotam","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1186\/2110-5820-3-17_bb0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/VHRM.S2471","article-title":"Perioperative hypertension management","volume":"4","author":"Varon","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1186\/2110-5820-3-17_bb0220","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2165\/00003495-200666130-00010","article-title":"Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications","volume":"66","author":"Curran","year":"2006","journal-title":"Drugs"},{"key":"10.1186\/2110-5820-3-17_bb0225","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/cc10289","article-title":"CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department","volume":"15","author":"Peacock","year":"2011","journal-title":"Crit Care"},{"key":"10.1186\/2110-5820-3-17_bb0230","doi-asserted-by":"crossref","first-page":"e002338","DOI":"10.1136\/bmjopen-2012-002338","article-title":"Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial","volume":"3","author":"Cannon","year":"2013","journal-title":"BMJ Open"},{"key":"10.1186\/2110-5820-3-17_bb0235","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcrc.2011.12.005","article-title":"Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients","volume":"27","author":"Malesker","year":"2012","journal-title":"J Crit Care"},{"key":"10.1186\/2110-5820-3-17_bb0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03256583","article-title":"Clevidipine: a review of its use in the management of acute hypertension","volume":"9","author":"Deeks","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1186\/2110-5820-3-17_bb0245","first-page":"457","article-title":"Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review","volume":"6","author":"Awad","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1186\/2110-5820-3-17_bb0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinthera.2010.01.025","article-title":"Clevidipine for the treatment of severe hypertension in adults","volume":"32","author":"Nguyen","year":"2010","journal-title":"Clin Ther"},{"key":"10.1186\/2110-5820-3-17_bb0255","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1213\/ane.0b013e31818240db","article-title":"The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients","volume":"107","author":"Aronson","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1186\/2110-5820-3-17_bb0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1751-7133.2009.00133.x","article-title":"Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis","volume":"16","author":"Peacock","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1186\/2110-5820-3-17_bb0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/08037051.2010.539317","article-title":"Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis","volume":"1","author":"Peacock","year":"2011","journal-title":"Blood Press Suppl"},{"key":"10.1186\/2110-5820-3-17_bb0270","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11906-006-0065-0","article-title":"The latest generation of beta-blockers: new pharmacologic properties","volume":"8","author":"Pedersen","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"10.1186\/2110-5820-3-17_bb0275","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3949\/ccjm.76a.09030","article-title":"Beta-blockers for hypertension: are they going out of style?","volume":"76","author":"Che","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"10.1186\/2110-5820-3-17_bb0280","article-title":"Beta-blockers for hypertension","volume":"11","author":"Wiysonge","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/2110-5820-3-17_bb0285","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003495-200868030-00003","article-title":"Treatment of acute severe hypertension: current and newer agents","volume":"68","author":"Varon","year":"2008","journal-title":"Drugs"},{"key":"10.1186\/2110-5820-3-17_bb0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/clc.20249","article-title":"Current and future status of beta-blockers in the treatment of hypertension","volume":"31","author":"Chrysant","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1186\/2110-5820-3-17_bb0295","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CRD.0b013e3181c307b7","article-title":"Hypertensive crisis","volume":"18","author":"Rodriguez","year":"2010","journal-title":"Cardiol Rev"},{"key":"10.1186\/2110-5820-3-17_bb0300","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1378\/chest.93.2.398","article-title":"Managing critically ill patients with esmolol, An ultra short-acting beta-adrenergic blocker","volume":"93","author":"Gray","year":"1988","journal-title":"Chest"},{"key":"10.1186\/2110-5820-3-17_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3949\/ccjm.61.1.59","article-title":"Labetalol and other agents that block both alpha- and beta-adrenergic receptors","volume":"61","author":"Pearce","year":"1994","journal-title":"Cleve Clin J Med"},{"key":"10.1186\/2110-5820-3-17_bb0310","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2146\/ajhp090619","article-title":"Phentolamine continuous infusion in a patient with pheochromocytoma","volume":"68","author":"McMillian","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1186\/2110-5820-3-17_bb0315","first-page":"297","article-title":"Endocrine arterial hypertension: therapeutic approach in clinical practice","volume":"33","author":"Mazza","year":"2008","journal-title":"Minerva Endocrinol"},{"key":"10.1186\/2110-5820-3-17_bb0320","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/00003495-199856050-00016","article-title":"Urapidil, A reappraisal of its use in the management of hypertension","volume":"56","author":"Dooley","year":"1998","journal-title":"Drugs"},{"key":"10.1186\/2110-5820-3-17_bb0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2125.2000.00219.x","article-title":"The acute vascular effects of frusemide in heart failure","volume":"50","author":"Jhund","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1186\/2110-5820-3-17_bb0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1267\/ahc.09006","article-title":"The effects of diuretics on intracellular Ca2+ dynamics of arteriole smooth muscles as revealed by laser confocal microscopy","volume":"42","author":"Tamagawa","year":"2009","journal-title":"Acta Histochem Cytochem"},{"key":"10.1186\/2110-5820-3-17_bb0335","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2174\/138945009788982478","article-title":"Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug","volume":"10","author":"Gregoretti","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1186\/2110-5820-3-17_bb0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00002512-200017020-00005","article-title":"I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly","volume":"17","author":"Prichard","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1186\/2110-5820-3-17_bb0345","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0970-9185.74581","article-title":"Clonidine in adults as a sedative agent in the intensive care unit","volume":"26","author":"Jamadarkhana","year":"2010","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1186\/2110-5820-3-17_bb0350","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ajhp\/56.6.572","article-title":"Intravenous clonidine for hypertensive emergencies","volume":"56","author":"Cline","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1186\/2110-5820-3-17_bb0355","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1213\/01.ane.0000246399.10396.15","article-title":"Using dexmedetomidine to manage patients with cocaine and opioid withdrawal, who are undergoing cerebral angioplasty for cerebral vasospasm","volume":"103","author":"Farag","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1186\/2110-5820-3-17_bb0360","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.122.1.311","article-title":"Clinical, diagnostic, and management perspectives of aortic dissection","volume":"122","author":"Khan","year":"2002","journal-title":"Chest"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025015766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025015766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2110-5820-3-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:14:04Z","timestamp":1776669244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025015766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["S2110582025015766"],"URL":"https:\/\/doi.org\/10.1186\/2110-5820-3-17","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of hypertension in the critically ill: a pathophysiological approach","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/2110-5820-3-17","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Ribeiro Salgado et al.; licensee Springer. 2013. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"17"}}